Opportunity Analysis

Loading opportunity analysis

Pulling together the market signals, competitive context, and launch strategy.

SaaS Browser

Loading your next opportunity

Preparing the latest market signals, analysis, and workspace data.

Executive Summary

Systematic reviews and evidence syntheses remain painfully manual: teams routinely screen thousands of PDFs, extract structured outcomes, and assemble auditable datasets by hand, consuming months of labor and significant budget. This burden falls on an estimated 600,000 research teams across universities, pharma R&D, NGOs and clinical review units and supports a roughly $3.6B market at an average contract value near $6,000 per team. You could build an AI-powered PDF screening and data-extraction platform that pairs LLM/document-AI models with human-in-the-loop workflows: automated deduplication, title/abstract and full-text triage, PICO/outcome and table extraction, risk-of-bias suggestions, PRISMA flow generation, and integrations with common reference managers and review platforms. Critical product requirements are auditable provenance for every extracted datapoint, per-item confidence scores with easy reviewer overrides, and enterprise features (SAML, on‑prem or VPC deployment) for pharma and regulated customers. Operationalizing this means validating models on labeled corpora and reporting measurable accuracy—e.g., targeting screening recall >95% at usable precision—so reviewers will accept workload reductions without compromising reproducibility. The timing is favorable: advances in LLMs and document-AI materially improve extraction, reproducibility mandates increase demand for auditable workflows, and growth in industry-sponsored reviews raises willingness to pay; market and revenue potential are strong (Market Score 85/100, Revenue Potential 82/100) even with medium competition. To win you must deliver demonstrable end-to-end accuracy, transparent audit trails, validated ROI (time saved per review), and enterprise-grade privacy; expect real challenges from messy PDFs, integration inertia in academic groups, and the need to convert cautious reviewers through independent validations rather than marketing claims.

Manual systematic review screening — AI-powered PDF screening and data extraction

Executive Summary

Market Validation

Manual systematic review screening — AI-powered PDF screening and data extraction

Executive Summary

Market Validation

More in B2B Software

Small-business grant discovery — centralized database + automated alerts

Streamline dealership ops — centralize inventory, leads, docs & payments

Early-traction trap: convert one-off signups into repeat video-contract users

Manual quoting & installs — AI visual quoting + field workflow automation

Outdated workflows: autonomous AI agents orchestrating ops & data (pain → AI OS)

Map processes first — prevent automating broken manual workflows

Market Opportunity

More in B2B Software

Small-business grant discovery — centralized database + automated alerts

Streamline dealership ops — centralize inventory, leads, docs & payments

Early-traction trap: convert one-off signups into repeat video-contract users

Manual quoting & installs — AI visual quoting + field workflow automation

Outdated workflows: autonomous AI agents orchestrating ops & data (pain → AI OS)

Map processes first — prevent automating broken manual workflows